✦ LIBER ✦

Lead and cancer in humans: Where are we now?

✍ Scribed by Kyle Steenland; Paolo Boffetta

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 124 KB
Volume: 38
Category: Article
ISSN: 0271-3586
DOI: 10.1002/1097-0274(200009)38:3<295::aid-ajim8>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer: Where we are now and goals for 2

Cancer: Where we are now and goals for 2015

✍ Gerald L. Woolam 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

Alcohol and breast cancer. Where are we

Alcohol and breast cancer. Where are we now where do we go from here?

✍ Arthur Schafzkin; Matthew P. Longnecker 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1023 KB

Understanding diabetic teratogenesis: Wh

Understanding diabetic teratogenesis: Where are we now and where are we going?

✍ Sheller Zabihi; Mary R. Loeken 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract Maternal pregestational diabetes (type 1 or type 2) poses an increased risk for a broad spectrum of birth defects. To our knowledge, this problem first came to the attention of the Teratology Society at the 14th Annual Meeting in Vancouver, B.C. in 1974, with a presentation by Lewis Hol

Dysconnectivity in schizophrenia: Where

Dysconnectivity in schizophrenia: Where are we now?

✍ William Pettersson-Yeo; Paul Allen; Stefania Benetti; Philip McGuire; Andrea Mec 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 640 KB

The disconnection hypothesis suggests that the core symptoms of schizophrenia (SZ) are related to aberrant, or 'dys-', connectivity between distinct brain regions. A proliferation of functional and structural neuroimaging studies have been conducted to investigate this hypothesis, across the full co

Teaching Style: Where Are We Now?

✍ Joe E. Heimlich; Emmalou Norland 📂 Article 📅 2002 🏛 John Wiley and Sons ⚖ 49 KB 👁 2 views

Dopamine D1 receptor ligands: Where are

Dopamine D1 receptor ligands: Where are we now and where are we going

✍ Jing Zhang; Bing Xiong; Xuechu Zhen; Ao Zhang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

The dopamine (DA) D(1) receptor is the most highly expressed DA receptor subtype among the DA receptor family. Although the first DA D(1) receptor selective ligand SCH-23390 (1) was introduced more than two decades ago, clinically useful D(1) receptor selective ligands are rare. A renewed interest w